Through this collaboration, Catalent supports Science 37’s Direct-to-Patient Clinical Trial Site model by providing reliable, efficient shipping and logistics services for study medications, ensuring ...

Ardena Acquired Catalent’s Somerset, NJ, oral solids development and small-scale drug product manufacturing facility for an undisclosed price, in a deal completed in February. In Somerset, expanded ...

Shares of Regeneron Pharmaceuticals (REGN) have lost 21.1% year to date against the industry’s growth of 5.2%. The stock has ...

A midstage study of the psychedelic drug LSD showed positive results for easing symptoms in people with generalized anxiety ...

While biologics are expected to drive CDMO growth through 2033, foreign exchange rates and tariffs are looming challenges.

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Precigen ( (PGEN)) has shared an update.

Novo Nordisk leads globally in GLP-1s despite U.S. pressure, with a strong pipeline, cost cuts, and attractive valuation.

This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter.

Novo Nordisk A/S is poised for long-term growth despite job cuts and margin resets. Click here to find out why NVO stock is a ...

Private equity company Permira is looking to offload its CDMO Cambrex in a sale that could value the latter company at up to ...

Denis Johnson became CEO on Sept. 1 at the Grand Rapids-based contract manufacturer Grand River Aseptic Manufacturing.

FDA inspection revealed contamination and equipment issues at Novo Nordisk's Bloomington plant, acquired from Catalent in 2024. Inspectors found atypical particles, including hair, and pest ...